143 related articles for article (PubMed ID: 10698503)
1. Somatic mutations and genetic polymorphisms of the PPP1R3 gene in patients with several types of cancers.
Takakura S; Kohno T; Shimizu K; Ohwada S; Okamoto A; Yokota J
Oncogene; 2000 Feb; 19(6):836-40. PubMed ID: 10698503
[TBL] [Abstract][Full Text] [Related]
2. PPP1R3 gene (protein phosphatase 1) alterations in colorectal cancer and its relationship to metastasis.
Hayashida Y; Goi T; Hirono Y; Katayama K; Urano T; Yamaguchi A
Oncol Rep; 2005 Jun; 13(6):1223-7. PubMed ID: 15870946
[TBL] [Abstract][Full Text] [Related]
3. Mutations truncating the EP300 acetylase in human cancers.
Gayther SA; Batley SJ; Linger L; Bannister A; Thorpe K; Chin SF; Daigo Y; Russell P; Wilson A; Sowter HM; Delhanty JD; Ponder BA; Kouzarides T; Caldas C
Nat Genet; 2000 Mar; 24(3):300-3. PubMed ID: 10700188
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the E-cadherin gene in human gynecologic cancers.
Risinger JI; Berchuck A; Kohler MF; Boyd J
Nat Genet; 1994 May; 7(1):98-102. PubMed ID: 8075649
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas.
Mimori K; Inoue H; Alder H; Ueo H; Tanaka Y; Mori M
Oncol Rep; 2001; 8(1):39-42. PubMed ID: 11115566
[TBL] [Abstract][Full Text] [Related]
6. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
7. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
[TBL] [Abstract][Full Text] [Related]
8. Absence of PPP2R1B gene alterations in primary ovarian cancers.
Campbell IG; Manolitsas T
Oncogene; 1999 Nov; 18(46):6367-9. PubMed ID: 10597236
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas.
Lee JW; Kim MR; Soung YH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
APMIS; 2006 Sep; 114(9):646-50. PubMed ID: 16948818
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of caspase-14 gene in common carcinomas.
Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH
Pathology; 2007 Jun; 39(3):330-3. PubMed ID: 17558860
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the PPP1R3 gene in human cancer.
Kohno T; Takakura S; Yamada T; Okamoto A; Tanaka T; Yokota J
Cancer Res; 1999 Sep; 59(17):4170-4. PubMed ID: 10485448
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of human ovarian carcinoma cell lines.
Yuan Y; Kim WH; Han HS; Lee JH; Park HS; Chung JK; Kang SB; Park JG
Gynecol Oncol; 1997 Sep; 66(3):378-87. PubMed ID: 9299249
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of PTPRT phosphatase domains in common human cancers.
Lee JW; Jeong EG; Lee SH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
APMIS; 2007 Jan; 115(1):47-51. PubMed ID: 17223850
[TBL] [Abstract][Full Text] [Related]
15. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
[TBL] [Abstract][Full Text] [Related]
16. Relationship between mitochondrial DNA mutations and clinical characteristics in human lung cancer.
Jin X; Zhang J; Gao Y; Ding K; Wang N; Zhou D; Jen J; Cheng S
Mitochondrion; 2007 Sep; 7(5):347-53. PubMed ID: 17707697
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
Lee JW; Soung YH; Kim SY; Lee HW; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
Oncogene; 2005 Feb; 24(8):1477-80. PubMed ID: 15608678
[TBL] [Abstract][Full Text] [Related]
18. PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers.
Tamaki M; Goi T; Hirono Y; Katayama K; Yamaguchi A
Oncol Rep; 2004 Mar; 11(3):655-9. PubMed ID: 14767517
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the BRCA2 gene in hepatocellular carcinomas.
Katagiri T; Nakamura Y; Miki Y
Cancer Res; 1996 Oct; 56(20):4575-7. PubMed ID: 8840963
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the PPP1R3 gene in hematological malignancies.
Inoue K; Kohno T; Takakura S; Morishita K; Takita J; Hayashi Y; Mizoguchi H; Yokota J
Int J Oncol; 2000 Oct; 17(4):717-21. PubMed ID: 10995882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
